X-Biotix

X-Biotix is a biotechnology company that specializes in developing novel small-molecule antibiotic scaffolds targeting multidrug-resistant (MDR) Gram-negative pathogens to address the urgent and growing global threat of antibiotic resistance. The company is applying a multi-target strategy to generate a robust pipeline of antibiotics with inhibitory activity against multiple biological targets within critical pathways of Gram-negative bacterial cells, which is expected to disrupt known mechanisms of antibiotic resistance.